The goal of this project is to isolate inhibitors of apoptosis that can activate autophagy. Apoptosis has been implicated in a wide array of human inflammatory and degenerative diseases. However, after more than 30 years of research, the field failed to deliver a target that can be pharmacologically manipulated to inhibit apoptosis, as direct inhibition of caspases leads to necroptosis. Activating autophagy will support cell survival under stress condition.

Funding

Funding Duration

July 1, 2017 - December 31, 2019

Funding level

Development

People

Principal Investigator

Junying Yuan

PhD
Elizabeth D. Hay Professor of Cell Biology, Harvard Medical School
Co-PI

Hong Zhu

BS
Associate in Cell Biology, Harvard Medical School

Intellectual Property

Publications

Patents

WO2021257697
:
Compounds and methods for blocking apoptosis and inducing autophagy
(Patent application)

Follow on Funding and Exits